United States v. Bacaner

CourtDistrict Court, M.D. Florida
DecidedMarch 18, 2022
Docket8:21-cv-00391
StatusUnknown

This text of United States v. Bacaner (United States v. Bacaner) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Bacaner, (M.D. Fla. 2022).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

UNITED STATES OF AMERICA,

Plaintiff,

v. Case No. 8:21-cv-391-VMC-SPF

TOBIAS BACANER, M.D., et al.,

Defendants. ______________________________/

ORDER This matter comes before the Court upon consideration of Plaintiff the United States of America’s Motion to Strike Dr. Daniel E. Buffington’s Expert Report and Exclude his Testimony. (Doc. # 106). Defendants Paragon Community Healthcare, Inc., Cobalt Pharmacy, Inc., Theodore Ferguson, II, and Timothy Ferguson (the “Paragon Defendants”) have filed a response in opposition. (Doc. # 110). For the reasons that follow, the Motion is granted. I. Background This case involves allegations that the Defendants unlawfully distributed and dispensed controlled substances out of their pain management clinic. (Doc. # 1). On October 26, 2021, the Paragon Defendants served their expert disclosure, which identified Dr. Daniel Buffington and attached his expert report. The substantive part of Dr. Buffington’s report is less than three pages long and purports to convey his opinions regarding seven topics: (1) the standard of care for pharmacists in the state of Florida; (2) that Cobalt Pharmacy and its staff did not deviate from the prevailing standard of care; (3) that the prescription “of combinations of

opioids with benzodiazepines is a common practice to address known side effects of effective pain medications and other comorbid conditions [and] [f]illing a prescription of these combinations of drugs, in and of themselves, is not a violation of the standard of care”; (4) that Cobalt Pharmacy complied with all Florida regulations and “did not deviate from the prevailing standard of care during its drug utilization review”; (5) “the morphine milligram equivalency (‘MME’) and morphine equivalent dose (‘MED’) and [] how drug selection and dosing of opioids for pain management is individualized to the unique needs of each patient”; (6) that there are no geographical restrictions on dispensing within Florida and so the distances between Cobalt Pharmacy and the

addresses of patients was not suspicious; and (7) that it is not a deviation from the standard of care for a pharmacy to accept cash payments from patients. (Doc. # 106-1 at 1-7). The United States has moved to strike Dr. Buffington’s report and exclude him as a witness in this case, arguing that the report “merely outlines in conclusory fashion the opinions Dr. Buffington anticipates testifying about without identifying the basis or reasons for them, including any specific facts or evidence that he relied on . . ., or the logical foundation that led him to his conclusions.” (Doc. # 106 at 1-2). The Paragon Defendants respond that the report meets the “basic requirements” of Rule 26(a)(2)(B). (Doc. # 110). They argue that Dr. Buffington’s allusions to the

pleadings and discovery in this case are appropriate because the government is well aware of the documents that were produced in discovery and so there can be no “genuine surprise to the government.” (Id. at 4). The Motion is ripe for review. II. Discussion Expert report disclosures are governed by Federal Rule of Civil Procedure 26. Rule 26(a)(2) requires a party to disclose to the other parties the identity of any expert witness it may use at trial to present evidence and, “[e]xcept as otherwise stipulated or directed by the court, this disclosure shall . . . be accompanied by a written report prepared and signed by the witness.” Fed. R. Civ. P. 26(a)(2). The expert’s written report

must contain: (i) a complete statement of all opinions the witness will express and the basis and reasons for them; (ii) the facts or data considered by the witness in forming them; (iii) any exhibits that will be used to summarize or support them; (iv) the witness’s qualifications, including a list of all publications authored in the previous 10 years; (v) a list of all other cases in which, during the previous 4 years, the witness testified as an expert at trial or by deposition; and (vi) a statement of the compensation to be paid for the study and testimony in the case.1

1 While the government also takes issue with the omission of Dr. Buffington’s testimonial history from the report, the Paragon Fed. R. Civ. P. 26(a)(2)(B). While Rule 26(a)(2)(B) “does not require that a report recite each minute fact or piece of scientific information that might be elicited on direct examination” it must be “detailed enough to provide the opposing party an opportunity to adequately cross examine the expert[.]” Kleiman v. Wright, No. 18-CV-80176, 2020 WL 6729362, at *5 (S.D. Fla. Nov. 16, 2020). Here, Dr. Buffington’s expert report does not comply with Rule 26(a)(2)(B)(i) and (ii)’s requirements that the expert

provide the basis or reasons for his proffered opinions and the facts or data considered in forming them. Instead, Dr. Buffington’s report offers only conclusory opinions purporting to cover seven different topics in less than three pages. The report cites no specific underlying facts, documents, publications, theories, or studies, but instead cites in a general fashion to “the relevant pleadings and available discovery” and the “available documentation and applicable law.” (Doc. # 106-1 at 5-6). For example, Dr. Buffington’s report states that he will opine that “Cobalt Pharmacy and its staff did not deviate from the prevailing standard of care for a Florida pharmacy.” (Id. at 5). The report

does not explain how or why Dr. Buffington reached this conclusion

Defendants represent that they “promptly rectified” this inadvertent omission. (Doc. # 110 at 7). and – beyond generally alluding to the “relevant pleadings and available discovery” – there is no indication of what documents Dr. Buffington looked at in forming this opinion. All of the

proffered opinions in the report suffer from similar infirmities. While the Paragon Defendants argue that the government must know the underlying facts due to its involvement in the investigation and discovery in this case, this reasoning does not suffice. An opposing party’s familiarity with the case does not absolve a party of its obligations under Rule 26. “If a party fails to provide information or identify a witness as required by Rule 26(a) or (e), the party is not allowed to use that information or witness to supply evidence on a motion, at a hearing, or at trial, unless the failure was substantially justified or is harmless.” Fed. R. Civ. P. 37(c)(1). The non- disclosing party bears the burden of showing that the failure was

substantially justified or harmless. Mitchell v. Ford Motor Co., 318 F. App’x 821, 824 (11th Cir. 2009). Substantial justification exists if there is “justification to a degree that could satisfy a reasonable person that parties could differ as to whether the party was required to comply with the disclosure request,” and a failure to disclose is harmless “when there is no prejudice to the party entitled to receive the disclosure.” Hewitt v. Liberty Mut. Grp., Inc., 268 F.R.D. 681, 682-83 (M.D. Fla. 2010) (quotation and citation omitted). In determining whether a failure to disclose evidence is substantially justified or harmless, courts are guided by the following factors: (1) the unfair prejudice or surprise of the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

OFS FITEL, LLC v. Epstein, Becker and Green, PC
549 F.3d 1344 (Eleventh Circuit, 2008)
Ernestine Mitchell v. Ford Motor Company
318 F. App'x 821 (Eleventh Circuit, 2009)
Hewitt v. Liberty Mutual Group, Inc.
268 F.R.D. 681 (M.D. Florida, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Bacaner, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-bacaner-flmd-2022.